Doctor profile · Federal record
Dr. SUMEET CHANDRA, M.D.
Medical Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Hematology & Oncology Physician · MELBOURNE, FL
- NPI 1801853171
- Accepts Medicare
- MIPS 95.1 / 100 · 2023
- 27 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2290 W EAU GALLIE BLVD, STE 202
MELBOURNE, FL 329353145
(321) 254-4776
fax (321) 254-4840
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- May 4, 2023
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State licenses (2)
- Florida #ME101674 · Florida #ME 101674
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1801853171. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
259,288
Distinct HCPCS
10
Medicare allowed
$3,128,481
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 90,750 | 60 | $1 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 57,120 | 19 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 34,200 | 22 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 19,000 | 19 | $3 | |
J0897 |
Injection, denosumab, 1 mg | 18,060 | 73 | $23 | |
J1453 |
Injection, fosaprepitant, 1 mg | 14,850 | 20 | $0 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 3,900 | 38 | $21 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,560 | 21 | $7 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,974 | 44 | $0 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 2,440 | 18 | $8 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 3,077. This provider delivers 84× the peer median.Open Payments
Industry payments received
All-time total
$2,020
Transactions
62
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 11 | $246.45 | |
| Merck Sharp & Dohme LLC | 7 | $156.49 | |
| Janssen Biotech, Inc. | 4 | $116.83 | |
| Novartis Pharmaceuticals Corporation | 6 | $115.18 | |
| GlaxoSmithKline, LLC. | 5 | $105.23 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $75.36 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $73.69 | |
| Eisai Inc. | 3 | $71.11 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70.96 | |
| SOBI, INC | 2 | $70.12 | |
| TAIHO ONCOLOGY, INC. | 3 | $70.12 | |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69.82 | |
| Incyte Corporation | 3 | $66.35 | |
| Astellas Pharma US Inc | 3 | $64.77 | |
| AstraZeneca Pharmaceuticals LP | 2 | $57.69 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
400
Patients
56
Total drug cost
$1,662,825
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 76 | 29 | $2,327 |
| Revlimid (Lenalidomide) | Brand | 61 | 0 | $1,043,314 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 36 | 16 | $2,227 |
| Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50) | Brand | 34 | 0 | $137,396 |
| Hydroxyurea | Generic | 32 | 11 | $1,064 |
| Lenalidomide | Generic | 27 | 0 | $282,481 |
| Xarelto (Rivaroxaban) | Brand | 22 | 0 | $14,152 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 21 | 0 | $1,168 |
| Tamoxifen Citrate | Generic | 20 | 0 | $728 |
| Oxycodone Hcl | Generic | 19 | 0 | $673 |